301 related articles for article (PubMed ID: 21966488)
21. The Prognostic Role of a Combined Fibrinogen and Neutrophil-to-Lymphocyte Ratio Score in Patients with Resectable Hepatocellular Carcinoma: A Retrospective Study.
Kong W; Xu H; Cheng J; Fang Z; Wang H; Zhang J; Wang X; Dai T; Gao Y
Med Sci Monit; 2020 Jan; 26():e918824. PubMed ID: 31929496
[TBL] [Abstract][Full Text] [Related]
22. Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio.
Wong L; Bozhilov K; Hernandez B; Kwee S; Chan O; Ellis L; LeMarchand L
Clin Mol Hepatol; 2019 Sep; 25(3):305-316. PubMed ID: 31001964
[TBL] [Abstract][Full Text] [Related]
23. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY
World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil-to-Lymphocyte Ratio Predicts High-Risk Explant Features and Waitlist Survival But Is Not Independently Associated With Recurrence or Survival Following Liver Transplantation for Hepatocellular Carcinoma.
Harding-Theobald E; Yao FYK; Mehta N
Liver Transpl; 2021 Jun; 27(6):818-829. PubMed ID: 33570786
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil-to-lymphocyte ratio predicts recurrence after radiofrequency ablation in hepatitis B virus infection.
Tajiri K; Baba H; Kawai K; Minemura M; Yasumura S; Takahara T; Sugiyama T
J Gastroenterol Hepatol; 2016 Jul; 31(7):1291-9. PubMed ID: 26729319
[TBL] [Abstract][Full Text] [Related]
26. The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma.
Sellers CM; Uhlig J; Ludwig JM; Pollak JS; Taddei TH; Stein SM; Lim JK; Kim HS
Cancer Med; 2021 Aug; 10(16):5395-5404. PubMed ID: 34318618
[TBL] [Abstract][Full Text] [Related]
27. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI).
Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597
[TBL] [Abstract][Full Text] [Related]
28. Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival and Liver Toxicity in Patients With Hepatocellular Carcinoma Treated With Stereotactic Ablative Radiation Therapy.
Lo CH; Lee HL; Hsiang CW; Chiou JF; Lee MS; Chen SW; Shen PC; Lin CS; Chang WC; Yang JF; Dai YH; Chen CY; Chia-Hsien Cheng J; Huang WY
Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):474-484. PubMed ID: 32898609
[TBL] [Abstract][Full Text] [Related]
29. Recurrence After Liver Transplantation for Hepatocellular Carcinoma: A New MORAL to the Story.
Halazun KJ; Najjar M; Abdelmessih RM; Samstein B; Griesemer AD; Guarrera JV; Kato T; Verna EC; Emond JC; Brown RS
Ann Surg; 2017 Mar; 265(3):557-564. PubMed ID: 27611615
[TBL] [Abstract][Full Text] [Related]
30. Pretransplant Elevated Plasma Fibrinogen Level is a Novel Prognostic Predictor for Hepatocellular Carcinoma Recurrence and Patient Survival Following Liver Transplantation.
Wang GY; Jiang N; Yi HM; Wang GS; Zhang JW; Li H; Zhang J; Zhang Q; Yang Y; Chen GH
Ann Transplant; 2016 Feb; 21():125-30. PubMed ID: 26903139
[TBL] [Abstract][Full Text] [Related]
31. The Severity of Liver Fibrosis Influences the Prognostic Value of Inflammation-Based Scores in Hepatitis B-Associated Hepatocellular Carcinoma.
Wang Q; Blank S; Fiel MI; Kadri H; Luan W; Warren L; Zhu A; Deaderick PA; Sarpel U; Labow DM; Hiotis SP
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1125-32. PubMed ID: 26159441
[TBL] [Abstract][Full Text] [Related]
32. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis.
Li SH; Wang QX; Yang ZY; Jiang W; Li C; Sun P; Wei W; Shi M; Guo RP
World J Gastroenterol; 2017 May; 23(17):3122-3132. PubMed ID: 28533669
[TBL] [Abstract][Full Text] [Related]
34. Inflammation-Based Prognostic Scores in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma After Liver Transplantation.
Ren A; Li Z; Zhang X; Deng R; Ma Y
J Hepatocell Carcinoma; 2020; 7():101-106. PubMed ID: 32766175
[TBL] [Abstract][Full Text] [Related]
35. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
36. Prognostic effect of preoperative neutrophil-lymphocyte ratio is related with tumor necrosis and tumor-infiltrating lymphocytes in hepatocellular carcinoma.
Ha SY; Choi S; Park S; Kim JM; Choi GS; Joh JW; Park CK
Virchows Arch; 2020 Dec; 477(6):807-816. PubMed ID: 32483662
[TBL] [Abstract][Full Text] [Related]
37. High neutrophil-lymphocyte ratio indicates poor prognosis for acute-on-chronic liver failure after liver transplantation.
Lin BY; Zhou L; Geng L; Zheng ZY; Jia JJ; Zhang J; Yao J; Zheng SS
World J Gastroenterol; 2015 Mar; 21(11):3317-24. PubMed ID: 25805939
[TBL] [Abstract][Full Text] [Related]
38. Predictive value of the preoperative neutrophil-to-lymphocyte ratio for the development of hepatocellular carcinoma in HBV-associated cirrhotic patients after splenectomy.
Du Z; Dong J; Bi J; Bai R; Zhang J; Wu Z; Lv Y; Zhang X; Wu R
PLoS One; 2018; 13(4):e0195336. PubMed ID: 29621282
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory markers as selection criteria of hepatocellular carcinoma in living-donor liver transplantation.
Na GH; Kim DG; Han JH; Kim EY; Lee SH; Hong TH; You YK
World J Gastroenterol; 2014 Jun; 20(21):6594-601. PubMed ID: 24914382
[TBL] [Abstract][Full Text] [Related]
40. A novel prognostic score model based on combining systemic and hepatic inflammation markers in the prognosis of HBV-associated hepatocellular carcinoma patients.
Zhang T; Liu Z; Zhao X; Mao Z; Bai L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2246-2255. PubMed ID: 31169437
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
